Establishes tianeptine as Schedule II controlled dangerous substance.

This bill classifies tianeptine (a medication sometimes misused for its opioid-like effects) as a Schedule II controlled substance in New Jersey, meaning it now requires a prescription for medical use and is strictly regulated. It directly affects individuals who possess or distribute tianeptine without authorization, including those misusing it recreationally. The key provision adds tianeptine explicitly to Schedule II, requiring prescriptions and making unauthorized possession a crime. The bill cites the Drug Enforcement Administration's concern about tianeptine's rapid rise in illicit use and associated health risks like respiratory depression and overdose. (Note: The bill was withdrawn after being approved as P.L.2025, c.249, so it is now law.)